Literature DB >> 21732111

Real-time polymerase chain reaction and intraocular antibody production for the diagnosis of viral versus toxoplasmic infectious posterior uveitis.

Marie-Hélène Errera1, Pablo Goldschmidt, Laurence Batellier, Sandrine Degorge, Emmanuel Héron, Laurent Laroche, José-Alain Sahel, Mark Westcott, Christine Chaumeil.   

Abstract

PURPOSE: The aim of this work was to determine the diagnostic performance of real-time polymerase chain reaction (RT-PCR) and to assess intraocular specific antibody secretion (Goldmann-Witmer coefficient) on samples from patients with signs of posterior uveitis presumably of infectious origin and to target the use of these two biologic tests in the diagnostic of Toxoplasma/viral Herpesviridae posterior uveitis by the consideration of clinical behavior and delay of intraocular sampling.
METHODS: Aqueous humour and/or vitreous fluid were collected from patients suspected of having posterior uveitis of infectious origin at presentation (140 samples). The diagnosis was confirmed by quantification of antibodies with the Goldmann-Witmer coefficient (GWC) and for detection of Herpesviridae and Toxoplasma gondii genomes with RT-PCR. Forty-one patients had final diagnosis of uveitis of non-Toxoplasma/non-viral origin and 35 among them constituted the control group. The main outcome measures were sensitivity, specificity, and positive and negative predictive values (PPV and NPV).
RESULTS: When pre-intraocular testing indication was compared with final diagnosis, GWC was a more sensitive and specific method than RT-PCR, and was successful in detecting T. gondii, especially if the patient is immunocompetent and the testing is carried out later in the disease course, up to 15 months. For viral Herpesviridae uveitis, the sensitivity and PPV of PCR evaluation was higher than detected with GWC with respectively 46% compared with 20% for sensitivity and 85% versus 60% for PPV. In either viral retinitis or toxoplasmosis infection, RT-PCR results were positive from 24 h, although GWC was not significant until 1 week after the onset of signs. In toxoplasmosis patients, positive RT-PCR results were statistically correlated with the chorioretinitis area (more than three disc areas; p = 0.002), with the age older than 50 (p = 0.0034) and with a clinical anterior inflammation (Tyndall ≥1/2+) and panuveitis; (p = 0.0001).
CONCLUSIONS: For the diagnosis of viral or toxoplasmosis-associated intraocular inflammation, the usefulness of laboratory diagnosis tools (RT-PCR and GWC) depends on parameters other than the sensitivity of the tests. Certain patient characteristics such as the age of the patients, immune status, duration since the onset of symptoms, retinitis area, predominant site and extent of inflammation within the eye should orientate the rational for the choice of laboratory testing in analysis of intraocular fluids.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21732111     DOI: 10.1007/s00417-011-1724-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  36 in total

Review 1.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

2.  [Intraocular fluids analysis for etiologic diagnosis of presumed infectious uveitis].

Authors:  C Vasseneix; B Bodaghi; M Muraine; L Favennec; G Brasseur
Journal:  J Fr Ophtalmol       Date:  2006-04       Impact factor: 0.818

3.  Interpretation of intraocular and serum antibody levels in necrotizing retinitis.

Authors:  J L Davis; W Feuer; W W Culbertson; S C Pflugfelder
Journal:  Retina       Date:  1995       Impact factor: 4.256

4.  Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society.

Authors:  G N Holland
Journal:  Am J Ophthalmol       Date:  1994-05-15       Impact factor: 5.258

5.  Ocular toxoplasmosis after the fifth decade.

Authors:  Pierre Labalette; Laurence Delhaes; Fabrice Margaron; Bernard Fortier; Jean-François Rouland
Journal:  Am J Ophthalmol       Date:  2002-04       Impact factor: 5.258

6.  Diagnosing herpesvirus infections by real-time amplification and rapid culture.

Authors:  G J J van Doornum; J Guldemeester; A D M E Osterhaus; H G M Niesters
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

7.  Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features.

Authors:  Christine Fardeau; Stéphane Romand; Narsing A Rao; Nathalie Cassoux; Olivier Bettembourg; Philippe Thulliez; Phuc Lehoang
Journal:  Am J Ophthalmol       Date:  2002-08       Impact factor: 5.258

8.  International Uveitis Study Group (IUSG): clinical classification of uveitis.

Authors:  Jean Deschenes; Philip I Murray; Narsing A Rao; Robert B Nussenblatt
Journal:  Ocul Immunol Inflamm       Date:  2008 Jan-Feb       Impact factor: 3.070

9.  International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS).

Authors:  Carl P Herbort; Narsing A Rao; Manabu Mochizuki
Journal:  Ocul Immunol Inflamm       Date:  2009 May-Jun       Impact factor: 3.070

Review 10.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

View more
  11 in total

1.  Infectious causes of posterior uveitis and panuveitis in Thailand.

Authors:  Natedao Kongyai; Kessara Pathanapitoon; Wasna Sirirungsi; Paradee Kunavisarut; Jolanda D F de Groot-Mijnes; Aniki Rothova
Journal:  Jpn J Ophthalmol       Date:  2012-04-28       Impact factor: 2.447

Review 2.  Diagnostic vitrectomy for infectious uveitis.

Authors:  Abdallah Jeroudi; Steven Yeh
Journal:  Int Ophthalmol Clin       Date:  2014

Review 3.  Diagnostic dilemmas in retinitis and endophthalmitis.

Authors:  J L Davis
Journal:  Eye (Lond)       Date:  2011-11-25       Impact factor: 3.775

Review 4.  Infectious Uveitis in Horses and New Insights in Its Leptospiral Biofilm-Related Pathogenesis.

Authors:  Bettina Wollanke; Hartmut Gerhards; Kerstin Ackermann
Journal:  Microorganisms       Date:  2022-02-07

5.  Visual outcomes and ocular morbidity of patients with uveitis referred to a tertiary center during first year of follow-up.

Authors:  F Groen; W Ramdas; J de Hoog; J R Vingerling; A Rothova
Journal:  Eye (Lond)       Date:  2016-01-08       Impact factor: 3.775

6.  Evaluation of the reactive T-cell infiltrate in uveitis and intraocular lymphoma with flow cytometry of vitreous fluid (an American Ophthalmological Society thesis).

Authors:  Janet L Davis; Philip Ruiz; Milan Shah; Efrem D Mandelcorn
Journal:  Trans Am Ophthalmol Soc       Date:  2012-12

7.  Clinical Features and Outcomes of Patients With Tubercular Uveitis Treated With Antitubercular Therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1.

Authors:  Rupesh Agrawal; Dinesh Visva Gunasekeran; Robert Grant; Aniruddha Agarwal; Onn Min Kon; Quan Dong Nguyen; Carlos Pavesio; Vishali Gupta
Journal:  JAMA Ophthalmol       Date:  2017-12-01       Impact factor: 7.389

8.  The value of routine polymerase chain reaction analysis of intraocular fluid specimens in the diagnosis of infectious posterior uveitis.

Authors:  Marius A Scheepers; Karin A Lecuona; Graeme Rogers; Catey Bunce; Craig Corcoran; Michel Michaelides
Journal:  ScientificWorldJournal       Date:  2013-10-22

9.  Rhegmatogenous retinal detachment in uveitis.

Authors:  Joeri De Hoog; Josianne C Ten Berge; Fahriye Groen; Aniki Rothova
Journal:  J Ophthalmic Inflamm Infect       Date:  2017-11-21

10.  Coinfections and differential diagnosis in immunocompetent patients with uveitis of infectious origin.

Authors:  Alejandra de-la-Torre; Juanita Valdés-Camacho; Clara López de Mesa; Andrés Uauy-Nazal; Juan David Zuluaga; Lina María Ramírez-Páez; Felipe Durán; Elizabeth Torres-Morales; Jessica Triviño; Mateo Murillo; Alba Cristina Peñaranda; Juan Carlos Sepúlveda-Arias; Jorge Enrique Gómez-Marín
Journal:  BMC Infect Dis       Date:  2019-01-25       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.